Insider Shareholders with Direct Ownership of Biovie Inc. (BIVI)
This section provides a comprehensive overview of the insiders with direct ownership of Biovie Inc. (BIVI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
BIOVIE INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Terren S Peizer
Director |
3,200 | 0 | 4,258,956 $9.07 Million | 2 |
Jan 02, 2020
Added 0.04%
|
|
Joseph M Palumbo
Chief Medical Officer |
155,624 | 36,428 | 119,196 $253,887 | 5 |
Jun 24, 2024
Reduced 19.57%
|
|
Joanne Wendy Kim
Chief Financial Officer |
119,624 | 25,678 | 93,940 $200,092 | 7 |
Jun 24, 2024
Reduced 16.27%
|
|
Richard J Berman
Director |
97,008 | 32,773 | 69,235 $147,470 | 8 |
Nov 09, 2023
Added 42.81%
|
|
Cuong V Do
President & CEO |
31,710 | 0 | 68,759 $146,456 | 2 |
Nov 30, 2023
Added 12.7%
|
|
James Paul Lang
Director |
43,578 | 0 | 68,622 $146,164 | 1 |
Nov 23, 2022
Added 38.84%
|
|
Jonathan M Adams
EVP Liver Cirrhosis Programs |
0 | 11,000 | 48,630 $103,581 | 2 |
Feb 02, 2022
Reduced 2.01%
|
|
Penelope Markham
EVP Liver Cirrhosis R&D |
39,624 | 2,476 | 47,841 $101,901 | 2 |
Feb 16, 2023
Reduced 4.92%
|
|
Steve Gorlin
Director |
120,598 | 84,240 | 46,358 $98,742 | 11 |
Dec 01, 2023
Reduced 62.01%
|
|
Robert J Hariri
Director |
76,494 | 0 | 42,254 $90,001 | 2 |
Nov 09, 2023
Added 50.0%
|
|
Sigmund Rogich
Director |
42,254 | 0 | 42,254 $90,001 | 1 |
Nov 09, 2023
Added 50.0%
|
|
Christopher Reading
EVP Neuroscience R&D |
39,624 | 2,476 | 37,148 $79,125 | 2 |
Feb 16, 2023
Reduced 6.25%
|
|
Clarence N. Ahlem
EVP Neuroscience Product Dev. |
39,624 | 2,476 | 37,148 $79,125 | 2 |
Feb 16, 2023
Reduced 6.25%
|